Global Assisted reproductive technology Market

Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Product(Instrument, Accessory & Disposable and Reagents & Media), By Technology(In Vitro-Fertilization, Artificial Insemination and Others), By End User(Fertility Clinic, Hospital, Surgical Center and Clinical Research Institute), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2228 | Region: Global | Published Date: July, 2024
Pages: 165 | Tables: 91 | Figures: 76

Assisted Reproductive Technology Market Insights

Global Assisted Reproductive Technology Market size was valued at USD 25.30 Billion in 2022 poised to grow from USD 26.67 Billion in 2023 to USD 40.67 Billion by 2031, growing at a CAGR of 5.40% in the forecast period (2024-2031). 

Assisted Reproductive Technology (ART) helps single persons or couples conceive through the application of medical practices and methods. These technologies are aimed at helping those unable to conceive naturally or need additional assistance in fertility combating different impediments and challenges. Assisted reproductive technologies (ART) are a wide-ranging term for several treatments including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and gestational surrogacy. These techniques involve the handling of human sperm, eggs and embryos in vitro, leading to the insertion of such embryos into a woman’s uterus or fallopian tube.     

The prevalence of infertility is rising, funding for infertility services is coming from both private and public organizations, awareness of infertility treatment and surrogacy is growing, and technological advancements in assisted reproductive technology are the main factors driving the growth of the global market for these services. The World Health Organization (WHO) estimates that 48 million couples and 186 million individuals will receive an infertility diagnosis in 2020. The Centres for Disease Control and Prevention (CDC) estimate that 6% to 12% of American women with PCOS also had an infertility diagnosis. Consequently, rising PCOS incidence raises the risk of infertility and propels the market for assisted reproductive technologies. 

US Assisted Reproductive Technology Market  is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Assisted Reproductive Technology Market size was valued at USD 25.30 Billion in 2022 poised to grow from USD 26.67 Billion in 2023 to USD 40.67 Billion by 2031, growing at a CAGR of 5.40% in the forecast period (2024-2031). 

Global aided reproductive technology (ART) market is highly competitive as major companies pursue innovative solutions through advanced technologies. Key players include CooperSurgical who offers a variety of ART products, IVF Technologies which was the first to develop ART techniques and Ferring Pharmaceuticals widely recognized for its fertility drugs. To improve success rates and meet increasing demand for ART worldwide, these companies are engaged in R&D activities, forming alliances and expanding their services.  'Ferring Pharmaceuticals (Switzerland) ', 'CooperSurgical, Inc. (US) ', 'IVF Technologies (USA) ', 'Merck KGaA (Germany) ', 'Genea Biomedx (Australia) ', 'Hamilton Thorne Ltd. (Canada) ', 'Vitrolife AB (Sweden) ', 'LABORIE (Canada) ', 'ESN (France) ', 'MedTec (USA) ', 'CryoLife, Inc. (USA) ', 'Nantong Egens Biotechnology Co., Ltd. (China) ', 'Research Instruments Ltd. (UK) ', 'Sartorius AG (Germany) ', 'Thermo Fisher Scientific Inc. (USA) '

Infertility rates are increasing due to factors such as late childbearing, changes in lifestyle and environmental interactions; hence ART becomes very crucial. More and more couples want to solve their infertility problems, resulting in more demand for these services leading to increased growth of this industry. 

Expansion of Personalized ART Solutions: Due to advancements made in genetic screening and embryo analysis, the market is increasingly tilting in favor of individualized ART therapies. These tailored approaches aim at enhancing success rates and producing more efficient and focused fertility treatments by tackling the causes of infertility and considering individual patient concerns. 

Owing to its massive investments in health care administration, expanding human population and increasing infertility cases, the Asia-Pacific region is the kingpin of the global assisted reproductive technology market. Countries such as China and India are in need of assisted reproductive technologies (ART) because of changing social norms, rising awareness levels and easier access to modern reproductive technology. The region also gains from increased government funding, changing laws and policies, and an increase in fertility clinics providing state-of-the-art care. These elements coming together, combined with enhanced healthcare systems and economic growth, puts Asia-Pacific as a prominent market for ART, spurring its innovation and growth. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Assisted reproductive technology Market

Report ID: SQMIG35G2228

$5,300
BUY NOW GET FREE SAMPLE